{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:46:10Z","timestamp":1790916370411,"version":"4.1.0"},"reference-count":91,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,23]],"date-time":"2001-12-23T00:00:00Z","timestamp":1009065600000},"content-version":"vor","delay-in-days":113,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> Lymphoproliferative disorders associated with the Epstein\u2013Barr virus (EBV) include non\u2010Hodgkin\u2019s lymphoma, Hodgkin\u2019s lymphoma, and \u201cpost\u2010transplant lymphoproliferative disorders\u201d (PTLD), which occur with immunosuppression after marrow and organ transplantation. PTLD is characterized by actively proliferating, latently infected EBV(+) B\u2010lymphocytes, and often manifests a rapidly progressive fatal clinical course if the immunosuppression cannot be reversed. Lung transplant recipients are a subset of patients at special risk for developing PTLD. The incidence of PTLD development in these patients has been estimated at 5\u201310%. Whereas immunologic and antiviral therapy have been moderately effective for treating EBV\u2010associated infections in the lytic phase, they have been less useful in the more common latent phase of the disease. One common treatment for herpesvirus infections has targeted the virus\u2010specific enzyme thymidine kinase (TK). The lack of viral TK expression in EBV(+) tumor cells, due to viral latency, makes anti\u2010viral therapy alone ineffective as an anti\u2010neoplastic therapy, however. We have developed a strategy for the treatment of EBV\u2010associated lymphomas\/PTLD using pharmacologic induction of the latent viral <jats:italic>TK<\/jats:italic> gene and enzyme in the tumor cells, followed by treatment with ganciclovir. Arginine butyrate selectively activates the EBV <jats:italic>TK<\/jats:italic> gene in latently EBV\u2010infected human lymphoid cells and tumor cells. A Phase I\/II trial has been initiated, employing an intra\u2010patient dose escalation of arginine butyrate combined with ganciclovir. In six patients with EBV\u2010associated lymphomas or PTLD, all of which were resistant to conventional radiation and\/or chemotherapy, this combination produced complete clinical responses in four of six patients, with a partial response occurring in a fifth patient. Pathologic examination in two of three patients demonstrated complete necrosis of the EBV lymphoma, with no residual disease, following a single three\u2010week course of the combination therapy. Possible side\u2010effects of the therapy included nausea and reversible lethargy at the highest doses. One patient suffered acute liver failure, thought to be secondary to release of FasL from the necrotic tumor. Analysis of patient\u2010derived tumor cells in culture demonstrated that arginine butyrate produced selective induction of the EBV <jats:italic>TK<\/jats:italic> gene, which then conferred sensitivity to ganciclovir, resulting in tumor apoptosis. Additional patient accrual is sought for further evaluation of this therapy.<\/jats:p>","DOI":"10.1034\/j.1399-3062.2001.003003177.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T21:25:58Z","timestamp":1047504358000},"page":"177-185","source":"Crossref","is-referenced-by-count":59,"title":["Epstein\u2013Barr virus post\u2010transplant lymphoproliferative disease and virus\u2010specific therapy: pharmacological re\u2010activation of viral target genes with arginine butyrate"],"prefix":"10.1111","volume":"3","author":[{"given":"S.J.","family":"Mentzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Perrine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.V.","family":"Faller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,23]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.18004619704"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(64)92354-2"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5633.746"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1978.01370160119020"},{"key":"e_1_2_9_6_2","first-page":"108","article-title":"Epstein\u2013Barr virus\u2013associated diseases in humans","volume":"71","author":"Kawa K","year":"2000","journal-title":"Int J Hematol"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.4.248"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-200001000-00011"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.278.6.510"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.9.1395"},{"key":"e_1_2_9_11_2","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.4049\/jimmunol.162.3.1827","article-title":"A re\u2010evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers","volume":"162","author":"Tan LC","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_9_12_2","first-page":"1109","volume-title":"Fundamental Virology","author":"Kieff E","year":"1996"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.61.5.1743-1746.1987"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(91)90893-G"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.3.631"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-230X(08)60470-4"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.59.1.94"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00201468"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/2424"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.23.13765"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/26683"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199103000-00005"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19941101)74:9<2436::AID-CNCR2820740908>3.0.CO;2-S"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830180110"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/156.2.273"},{"key":"e_1_2_9_26_2","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1128\/jvi.65.2.976-980.1991","article-title":"Epstein\u2013Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4","volume":"65","author":"Cen H","year":"1991","journal-title":"J Virol"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199306000-00040"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.50.2.205"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199104000-00041"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198906000-00005"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198804000-00011"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80823-7"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/101.5.590"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19931101)72:9<2568::AID-CNCR2820720910>3.0.CO;2-D"},{"key":"e_1_2_9_35_2","first-page":"102","article-title":"Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis","volume":"88","author":"Palazzo JP","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_9_36_2","first-page":"736","article-title":"Malignant lymphomas in organ transplant recipients","volume":"13","author":"Penn I","year":"1981","journal-title":"Transplant Proc"},{"key":"e_1_2_9_37_2","first-page":"418","article-title":"Discrimination of Epstein\u2013Barr virus\u2010related post\u2010transplant lymphoproliferations from acute rejection in lung allograft recipients","volume":"119","author":"Rosendale B","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_9_38_2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood.V71.5.1234.1234","article-title":"Epstein\u2013Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation","volume":"71","author":"Shapiro RS","year":"1988","journal-title":"Blood"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.94.07030612"},{"key":"e_1_2_9_40_2","first-page":"261","article-title":"Post\u2010transplant mediastinal Burkitt\u2010like lymphoma. Diagnosis by cytologic and flow cytometric analysis of pleural fluid","volume":"34","author":"Wolford JF","year":"1990","journal-title":"Acta Cytol"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940615)73:12<3064::AID-CNCR2820731227>3.0.CO;2-0"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199606270-00010"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199012203232502"},{"key":"e_1_2_9_44_2","first-page":"21","article-title":"Overview of posttransplant B\u2010cell lymphoproliferative disorders","volume":"26","author":"Swinnen LJ","year":"1999","journal-title":"Semin Oncol"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002810050041"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199307000-00016"},{"key":"e_1_2_9_47_2","first-page":"877","article-title":"Post\u2010transplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine\u2010based immunosuppression","volume":"10","author":"Armitage JM","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199911270-00015"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.1998.0178"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404283301703"},{"key":"e_1_2_9_51_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V60.1.180.180","article-title":"A monoclonal immunoblastic sarcoma in donor cells bearing Epstein\u2013Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia","volume":"60","author":"Schubach WH","year":"1982","journal-title":"Blood"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1986.tb04450.x"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00329a034"},{"key":"e_1_2_9_54_2","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1128\/jvi.62.10.3892-3895.1988","article-title":"Characterization of the Epstein\u2013Barr virus\u2010encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems","volume":"62","author":"Littler E","year":"1988","journal-title":"J Virol"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1317968"},{"key":"e_1_2_9_56_2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/jvi.50.1.50-55.1984","article-title":"Prolonged inhibitory effect of 9\u2010(1,3\u2010dihydroxy\u20102\u2010propoxymethyl)guanine against replication of Epstein\u2013Barr virus","volume":"50","author":"Lin JC","year":"1984","journal-title":"J Virol"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.259.3.384"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-348"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb\/8.6.655"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.8.3054"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01309995"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830101)51:1<9::AID-CNCR2820510104>3.0.CO;2-4"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(87)90109-X"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05073.x"},{"key":"e_1_2_9_65_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301143280202"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199502020-00002"},{"key":"e_1_2_9_67_2","first-page":"1790","article-title":"Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease [see comments]","volume":"93","author":"Atweh GF","year":"1999","journal-title":"Blood"},{"key":"e_1_2_9_68_2","first-page":"465","article-title":"Butyrate\u2010induced G1 arrest results from p21\u2010independent disruption of retinoblastoma protein\u2010mediated signals","volume":"9","author":"Vaziri C","year":"1998","journal-title":"Cell Growth Differ"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1998.4370"},{"key":"e_1_2_9_70_2","first-page":"1584","article-title":"Initiation of growth arrest and apoptosis of MCF\u20107 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short\u2010chain fatty acid butyrate, is associated with mitochondrial activity","volume":"59","author":"Heerdt BG","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_9_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19990505)81:3<411::aid-ijc15>3.0.co;2-f"},{"key":"e_1_2_9_72_2","first-page":"897","article-title":"Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells","volume":"84","author":"Santini V","year":"1999","journal-title":"Haematologica"},{"key":"e_1_2_9_73_2","first-page":"713","article-title":"Butyrate\u2010induced apoptotic cascade in colonic carcinoma cells: modulation of the beta\u2010catenin\u2010Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin","volume":"10","author":"Bordonaro M","year":"1999","journal-title":"Cell Growth Differ"},{"key":"e_1_2_9_74_2","first-page":"5586","article-title":"The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells","volume":"59","author":"Giuliano M","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(87)90932-6"},{"key":"e_1_2_9_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)92999-9"},{"key":"e_1_2_9_77_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198204153061506"},{"key":"e_1_2_9_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)90210-0"},{"key":"e_1_2_9_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(82)80125-X"},{"key":"e_1_2_9_80_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198512193132502"},{"key":"e_1_2_9_81_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.2.552.552"},{"key":"e_1_2_9_82_2","first-page":"4262","article-title":"Polymorphic diffuse B\u2010cell hyperplasias and lymphomas in renal transplant recipients","volume":"41","author":"Frizzera G","year":"1981","journal-title":"Cancer Res"},{"key":"e_1_2_9_83_2","doi-asserted-by":"publisher","DOI":"10.1038\/2281056a0"},{"key":"e_1_2_9_84_2","first-page":"86","article-title":"Epstein\u2013Barr viral DNA in tissues of Hodgkin\u2019s disease","volume":"129","author":"Weiss LM","year":"1987","journal-title":"Am J Pathol"},{"key":"e_1_2_9_85_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198309000-00012"},{"key":"e_1_2_9_86_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198803243181203"},{"key":"e_1_2_9_87_2","first-page":"377","article-title":"Lymphoepithelial carcinoma of the stomach with Epstein\u2013Barr virus demonstrated by polymerase chain reaction","volume":"3","author":"Burke AP","year":"1990","journal-title":"Mod Pathol"},{"key":"e_1_2_9_88_2","first-page":"769","article-title":"Epstein\u2013Barr virus\u2010associated gastric adenocarcinoma","volume":"140","author":"Shibata D","year":"1992","journal-title":"Am J Pathol"},{"key":"e_1_2_9_89_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199501053320103"},{"key":"e_1_2_9_90_2","first-page":"39","article-title":"Epstein\u2013Barr virus in epithelial cell tumors: a breast cancer study","volume":"55","author":"Labrecque LG","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_9_91_2","first-page":"523","article-title":"Treatment of Epstein\u2013Barr virus (EBV)\u2010associated lymphomas and PTLD using arginine butyrate to induce viral TK gene expression: initial findings of a phase I\/II trial","volume":"94","author":"Faller DV","year":"1999","journal-title":"Blood"},{"key":"e_1_2_9_92_2","first-page":"544","article-title":"Phase I\/II trial of arginine butyrate to induce viral TK gene expression in Epstein\u2013Barr virus (EBV)\u2010associated lymphomas","volume":"41","author":"Faller DV","year":"2000","journal-title":"AACR Proc"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3062.2001.003003177.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3062.2001.003003177.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-3062.2001.003003177.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T22:09:42Z","timestamp":1697494182000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-3062.2001.003003177.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1034\/j.1399-3062.2001.003003177.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-3062.2001.003003177.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}